Bismuth subsalicylate
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble agrees to assist the U.S. Pharmacopeia in developing a draft monograph for the OTC overindulgence ingredient. The active ingredient in Pepto-Bismol is one of 55 OTC monograph ingredients identified in a March 17 letter from FDA to the Nonprescription Drug Manufacturers Association as lacking USP identity standards ("The Tan Sheet" March 28, p. 1)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning